Related content

Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts

By Nukatsuka Mamoru   Saito Hitoshi   Nakagawa Fumio   Abe Masaaki   Uchida Junji   Shibata Jiro   Matsuo Ken-ichi   Noguchi Shinzaburo   Kiniwa Mamoru  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

RNA Sequencing of MCF-7 Breast Cancer Cells Identifies Novel Estrogen-Responsive Genes with Functional Estrogen Receptor-Binding Sites in the Vicinity of Their Transcription Start Sites

By Yamaga Ryonosuke  

Hormones and Cancer, Vol. 4, Iss. 4, 2013-08 ,pp. : 222-232

Springer Publishing Company

Access to resources Recommend Favorite

Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth

By Tolhurst Robert  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 357-368

Springer Publishing Company

Access to resources Recommend Favorite

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

By Jonat Walter   Hilpert Felix  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 6, 2006-06 ,pp. : 343-355

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of Aromatase Inhibitors in Endocrine Responsive Breast Cancer: Lessons Learnt from Tamoxifen and CYP2D6 Genotyping

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 13, 2018-01 ,pp. : 1805-1813

Bentham Science Publishers

Access to resources Recommend Favorite